Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study


Korkmaz S., Dal M. S., Berber I., Sahin D. G., Dogu M. H., Ayyildiz O., ...More

GERIATRICS & GERONTOLOGY INTERNATIONAL, vol.15, no.6, pp.729-735, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 6
  • Publication Date: 2015
  • Doi Number: 10.1111/ggi.12341
  • Journal Name: GERIATRICS & GERONTOLOGY INTERNATIONAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Page Numbers: pp.729-735
  • Keywords: chronic myeloid leukemia, dasatinib, elderly patients, imatinib, nilotinib, CHRONIC-PHASE, MYELOPROLIFERATIVE DISORDERS, 1ST-LINE TREATMENT, IMATINIB TREATMENT, CML, INTERFERON, RECOMMENDATIONS, CYTARABINE, MANAGEMENT, NILOTINIB
  • Van Yüzüncü Yıl University Affiliated: Yes

Abstract

AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase inhibitors (TKI) therapy.